PFE Trading Analysis - 10/22/2026 04:47 PM — TRU-SENTIMENT

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below:

• Pfizer (PFE) recently advanced a late-stage obesity pill candidate into Phase 3, renewing investor interest in its metabolic pipeline beyond COVID products.
• The company confirmed a quarterly dividend of $1.72/year with an ex-dividend date of November 6, 2026, supporting income-focused holders.
• PFE shares pushed to a new 52-week high area in October 2026 as sentiment improved on cost-cutting and pipeline stabilization.
• No major earnings catalyst is scheduled before the next major options expiration (2026-11-20), though macro pharma pricing headlines remain a background risk.
• Context: The improved pipeline narrative aligns with the bullish options flow seen in the embedded data, even as near-term technicals look stretched.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for PFE:

• Trailing P/E is 39.60 with trailing EPS of $0.76; valuation is elevated versus many large-cap pharma peers historically trading lower multiples.
• Dividend yield is 5.71% with a dividend rate of $1.72 and ex-dividend date of 2026-11-06, reflecting income appeal.
• Market cap is $173,384,083,080.00 with shares outstanding of 5,699,674,000.00.
• Beta is low at 0.15, indicating minimal broad-market correlation; 52-week range is $23.62 to $30.25 (current price near the high).
• Institutional ownership is 44.41%; average volume is 29,981,000.00 shares.
• Historical volatility is 16.19%, consistent with a low-beta defensive profile.
• Missing fields: forward PE, PEG, price-to-book, revenue, margins, ROE, debt/equity, FCF, analyst target, and recommendation key are all null — fundamental trend quality cannot be assessed from data.
• Divergence: Price is at a 52-week high with rich P/E, yet the embedded option-spread engine flagged divergence between bullish sentiment and unclear technical direction.

Current Market Position

Current price per indicators is $30.37 (2026-10-22). Daily history shows a close of $30.37 on 2026-10-22 after an open of $30.05, high $30.44, low $29.88, and volume of 20,250,042.00 (above the 20-day avg of 19,399,501.00).

Minute bars (2026-10-21 to 2026-10-22) show opening around $30.00 and closing the final bar at $30.39 with a volume spike of 1,352,870.00 at 15:55, indicating late-session buying. Intraday low was $29.86 (first bar) and high was $30.44 (last day's bar).

Technical Analysis

SMAs are aligned bullishly: SMA 5 ($29.88) > SMA 20 ($28.72) > SMA 50 ($28.23), no bearish crossovers. RSI at 79.68 is overbought (>70), signaling stretched momentum. MACD (0.60) above signal (0.48) with positive histogram (0.12) confirms bullish momentum. Price is at the Bollinger upper band ($30.43), showing expansion and near-term exhaustion risk. The 30-day range is $27.12–$30.44; price is at the top 99% of the range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow is Bullish per True Sentiment. Call dollar volume is $2,287,945.00 (85.4%) vs put dollar volume of $390,899.00 (14.6%), total $2,678,844.00. Contracts: 17,524 calls vs 2,505 puts. This shows strong directional conviction to the upside.

Notable divergence: The option-spread engine returned "no_recommendation" due to divergence — options sentiment bullish but technicals show no clear direction (RSI overbought, price at band extreme). Pure directional positioning suggests near-term expectations of continued strength, but confirmation above $30.44 is needed.

Full chain details: PFE Options Flow

Key Price Levels (Observational Only)